AlphaYou
Overview
Smart money at a glance
Filings to Oct 12, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 5 added, 2 cutMore adding
Market overview
Fundamentals Jul 20- 52-wk high
- $123.99
- 52-wk low
- $71.13
- Mkt cap
- $9.81B
- Beta
- 1.14
- P/B
- 8.3x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -41.2%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about NUVL filings
Are insiders buying or selling Nuvalent Inc (NUVL) stock?
Neither. Nuvalent Inc (NUVL) insiders filed no open-market purchases or sales in the 90 days to Oct 12, 2026, according to SEC Form 4 filings.
Which members of Congress have traded NUVL recently?
None. No member of Congress disclosed a NUVL trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this NUVL smart-money data?
This summary uses filings available on Oct 12, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- BA
Balyasny
$128.1M
bought
- MI
Millennium
$48.1M
added
- BO
Bank of America
$86.1M
added
What insiders are doing
How top traders are positioned
No tracked top-trader positions in NUVL right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 4.1% above what analysts expected.
Last report
May 7, 2026
Period ending
Mar 31, 2026
Earnings per share
-$1.45 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Mar 31, 2026 | May 7, 2026 | -$1.39 / -$1.45Alpha Vantage | +4.14% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 26, 2026 | -$1.58 / -$1.48Alpha Vantage | -6.76% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 30, 2025 | -$1.70 / -$1.36Alpha Vantage | -25.00% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | -$1.39 / -$1.22Alpha Vantage | -13.93% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | -$1.18 / -$1.13Alpha Vantage | -4.42% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 27, 2025 | -$1.05 / -$1.08Alpha Vantage | +2.78% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | -$1.28 / -$0.94Alpha Vantage | -36.17% miss | Unavailable | Unavailable |
| Jun 30, 2024 | Aug 8, 2024 | -$0.88 / -$0.76Alpha Vantage | -15.32% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
What the street expects next
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| What it spent | ||||
| Research and development | $80.9M | $83.8M | $67.8M | $83.6M |
| Sales and admin | $23.7M | $28.9M | $34.4M | $35.8M |
| Total operating expenses | $104.6M | $112.7M | $102.2M | $119.4M |
| What was left | ||||
| Operating profit | -$104.6M | -$112.7M | -$102.2M | -$119.4M |
| Interest on debt | — | $10.2M | — | $12.9M |
| Profit before tax | -$99.5M | -$122.3M | -$118.6M | -$109.1M |
| Tax | $145.0K | $132.0K | $151.0K | $168.0K |
| Net profit | -$99.7M | -$122.4M | -$118.7M | -$109.3M |
| EBITDA | -$99.5M | -$122.3M | -$16.3M | -$96.2M |
Technicals
Price structure
Market data unavailable.